How do we treat people with dementia in Croatia

Psychiatria Danubina

Volumn 22, Issue 2, 2010, Pages 363-366

  Mimica, Ninoslav ^a,b   Presečki, Paola ^c  

^a Referentni centar za Alzheimerovu bolest i psihijatriju sta rijeivo t ne dobi   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Zagreb Fakultet za dentalnu medicinu i zdravstvo Osijek Zdravstveno veleu ili te Zagreb   (Croatia)

Author keywords

Alzheimer's disease; Antidementia drugs; Cholinesterase inhibitors; Croatia; Dementia; Memantine

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ARICEPT EVESS; ASCORBIC ACID; DONEPEZIL; DONEPEZIL PLIVA; ESTROGEN; GALANTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEMANTIN PLIVA; MEMANTINE; NOOTROPIC AGENT; OMEGA 3 FATTY ACID; PIRACETAM; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RIVASTIGMINE; TACRINE; TRACE ELEMENT; UNCLASSIFIED DRUG; YASNAL;

AGE DISTRIBUTION; ALCOHOLISM; ALGORITHM; ALZHEIMER DISEASE; ANXIETY DISORDER; COGNITIVE DEFECT; CONFERENCE PAPER; CROATIA; DATA BASE; DEMENTIA; DEPRESSION; DISEASE SEVERITY; DRUG APPROVAL; EMOTIONAL DISORDER; EUROPEAN UNION; FOOD AND DRUG ADMINISTRATION; GINKGO BILOBA; HEALTH CARE ORGANIZATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MANIA; MEDICAL SOCIETY; OBSESSIVE COMPULSIVE DISORDER; PRACTICE GUIDELINE; PRESENILE DEMENTIA; PREVALENCE; PSYCHOPHARMACOLOGY; PSYCHOSIS; REIMBURSEMENT; TREATMENT RESPONSE;

AGED; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; CROATIA; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DRUG APPROVAL; DRUG COSTS; HUMANS; INDANS; MEMANTINE; NATIONAL HEALTH PROGRAMS; NOOTROPIC AGENTS; PHENYLCARBAMATES; PIPERIDINES; REIMBURSEMENT MECHANISMS;

EID: 77954355297     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. Agronin ME: Alzheimer disease and other dementias: A practical guide, II edition. Lippincott Williams & Wilkins, Philadelphia, 2008.
2. Američka psihijatrijska udruga: Dijagnostički i statistički priručnik za duševne poremećaje, Četvrto izdanje, MeCrossed d signunarodna verzija. Naklada Slap, Jastrebarsko, 1996.
3. Bencarić L: Lista lijekova Hrvatskog zavoda za zdravstveno osiguranje (priručnik za primjenu). Udruga poslodavaca u zdravstvu, Zagreb, 2009.
4. Bencarić L: Registar lijekova u Hrvatskoj, pedeset treće izdanje. Udruga poslodavaca u zdravstvu, Zagreb, 2010.
5. Birks J: Cholinesterase inhibitors for Alzheimer's disease. Cochrane Databese Syst Rev 2006;(Suppl 1):CD005593.
6. Dementia in Europe - Yearbook 2006 including the Alzheimer Europe Annual Report 2005. Luxembourg: Alzheimer Europe, 2006, pp. 19-48.
7. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al: Alzheimer's Disease International, Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366(Suppl. 9503):2112-2117.
8. Folnegović-Šmalc V: Alzheimerova bolest. Medix 2007;13:147-149.
9. Folnegović-Šmalc V, Mimica N, Makarić G, Varda R & Silić A: Croatian therapeutic algorithm for treatment of Alzheimer's disease. Neurol Croat 2006;55(Suppl 4):38.
10. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, et al.: Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts, Neurologic Diseases in the Elderly Research Group. Neurology 2000;54(Suppl 5):S10-S15. (Pubitemid 30390599)
11. Giacobini E & Pepeu G (Eds): The Brain Cholinergic System in Health and Disease. Informa Healthcare, London, 2006.
12. Grand J & Feldman HH: Historical concepts of Alzheimer's disease and dementia. In: Feldman HH (Ed): Atlas of Alzheimer's disease. Informa Healthcare, London, 2007, pp. 1-26.
13. Hofman A, Rocca WA, Brayne C, Breteler MM, Clarke M, Cooper B et al.: The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings, Eurodem Prevalence Research Group. Int J Epidemiol 1991;20(Suppl. 3):736-748.
14. Hrvatski zavod za javno zdravstvo: MeCrossed d signunarodna klasifikacija bolesti i srodnih zdravstvenih problema, Deseta revizija, Svezak 1., Medicinska naklada, Zagreb, 1994
15. Jakovljević M, Vuksan-Ćusa B & Topić R: Some treatment dilemmas in rapidly developing dementia: a case report. World J Biol Psychiatry 2008;9:64-68.
16. Kraepelin E: Psychiatrie, Ein Lehrbuch für Studierende und Ärzte, Klinische Psychiatrie, Vol. 2, 8th Edition. Barth, Leipzig, 1910.
17. Lieberman JA & Tasman A: Handbook of psychiatric drugs, John Wiley & Sons, Chichester, 2006.
18. Mimica N: Contemporary treatment and care for people with Alzheimer's disease and Croatian reality. Period biol 2007;109(Suppl. 2):42.
19. Mimica N: The cholinesterase inhibitors - current clinical view and Croatian reality. 10th International Meeting on Cholinesterases, 20-25 September 2009, Programme and Abstracts, Šibenik, Croatia, 2009, pp. 73-74.
20. Mimica N, Dajčić M, Ivanković V, Pecotić Z, Šimić G, Kaćanski Vidas A & Presečki P: Alzheimer Disease Societies Croatia, 22nd Conference of Alzheimer's Disease International, Abstracts, 12-14 October 2006, Berlin, Germany, 2006a, pp. 102-103.
21. Mimica N, Dajčić M, Ivanković V, Pecotić Z, Šimić G & Vidas A: Hrvatska udruga za Alzheimerovu bolest. Lijec vjesn 2006b;128(Suppl 1):170-171.
22. Mimica N & Presečki P: Side effects of approved antidementives. Psychiatr Danub 2009;21(Suppl 1):108-113.
23. Mimica N & Presečki P: Current treatment options for people with Alzheimer's disease in Croatia. Chem Biol Interact 2010 doi:10.1016/j.cbi. 2010.03.029 .
24. Mimica N, Šimić G, Dajčić M, Mladinov M, Trešćec-Ivičić M, Novy-Radonić E & Glamuzina K: Alzheimer's disease and stigma fight in Croatia, 24th Conference of Alzheimer's Disease International, Programme and Abstracts Handbook, 25 - 28 March 2009, Singapore, 2009, pp. 68.
25. Mimica N, Šimić G, Grbić K, Novy-Radonić E, Ivanković V, Dajčić M et al.: Raising awareness of Alzheimer's dementia. Clin Neuropathol 2006c; 25(Suppl 6):303-304.
26. MKB-10 - Klasifikacija mentalnih poremećaja i poremećaja ponašanja: Klinički opisi i dijagnostičke smjernice, Deseta revizija, Medicinska naklada, Zagreb, 1999.
27. Pecotić Z &, Perkov D: Alzheimerova demencija, dijagnosticiranje, šifriranje i inicijalna terapija, II nadopunjeno izdanje, Hrvatska udruga za Alzheimerovu bolest, Zagreb, 2007.
28. Pecotić Z & Štengl-Martinjak M. Psihijatrijska bolnica Vrapče - Zagreb : Odjel za psihogerijatriju. In: Mimica N, Jukić V (Eds): Knjiga postera stručnjaka Psihijatrijske bolnice Vrapče 1978. - 2006. Psihijatrijska bolnica Vrapče, Zagreb, 2006, pp. 158-159.
29. Savezni zavod za zdravstvenu zaštitu: MeCrossed d signunarodna klasifikacija bolesti, povreda i uzroka smrti, prema osmoj reviziji iz 1965. godine, Knjiga I, Savremena administracija, Beograd, 1968a.
30. Savezni zavod za zdravstvenu zaštitu: MeCrossed d signunarodna klasifikacija bolesti, povreda i uzroka smrti, prema osmoj reviziji iz 1965. godine, Knjiga II - Alfabetski indeks, Savremena administracija, Beograd, 1968b.
31. Savezni zavod za zdravstvenu zaštitu: MeCrossed d signunarodna klasifikacija bolesti, povreda i uzroka smrti, prema devetoj reviziji iz 1975. godine, Knjiga 1. Institut za dokumentaciju zaštite na radu, Niš, 1978.
32. Silobrčić Radić M, Hrabak Žerjavić V: Epidemiological review of dementias in Croatia. Neurol Croat 2008;57(Suppl 4):95-96.
33. Stahl SM: Essential Psychopharmacology : The Prescriber's Guide. Cambridge University Press, Cambridge, 2005.
34. Szoeke CEI, Campbell S, Chiu E & Ames D: Vascular cognitive disorder. In: Weiner MF, Lipton AM (Eds): The American Psychiatric Publishing textbook of Alzheimer disease and other dementias. American Psychiatric Publishing, Inc., Arlington, 2009, pp. 181-194.
35. Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonalds S, Gergel I, Memantine Study Group. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 2004;291(Suppl 3):317-324.
36. Tomek Roksandić S, Žuškin E, Duraković Z, Smolej-Narančić N, Mustajbegović J, Pucarin- Cvetković J et al.: Ljudski vijek: doživjeti i nadživjeti 100 godina? Arh Hig Rada Toksikol 2009;60:375-386.
37. United Nations: Population Division, World Population Prospects, The 1998 Revision, Vol. II:Sex and Age, New York, 2000.
38. Vuksan-Ćusa B, Jakovljević M, Mimica N, Šagud M & Sartorius N: Algorithms for pharmacotherapy of dementia. Psychiatr Danub 2007;19:382-383.
39. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M et al: EFNS Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 2007;14(Suppl 1):e1-26.
40. Wertheimer-Baletić A: Demografija Hrvatske - dugoročni demografski procesi. In: Duraković Z (Ed): Gerijatrija: Medicina starije dobi. C. T. - Poslovne informacije, d.o.o., Zagreb, 2007, pp. 581-588.
41. Wilkinson D, Sganga A, Stave C & O'Connell B: Implications of the Facing Dementia Survey for health care professionals across Europe. Int J Clin Pract Suppl 2005;146:27-31. (Pubitemid 40333122)
42. World Health Organization: Atlas: country resources for neurological disorders 2004. WHO, Geneva, 2004. (http://www.who.int/mental-health/neurology/ neurogy-atlas-lr.pdf).
43. www.alz.co.uk/adi/
44. www.alzheimer.hr
45. www.alzheimer2010.com
46. www.cia.gov/library/publications/the-world-factbook/geos/hr.html
47. www.dzs.hr/hrv/censuses/census2001/census.htm
48. Yaari R, Tariot PN & Schneider LS: Cognitive enhancers and treatments for Alzheimer's disease. In: Psychiatry, Third Edition, Volume [2], Tasman A, Kay J, Lieberman JA, First MB, Maj M (Eds). John Wiley & Sons, Chichester, 2008, pp. 2294-2317.